206
Views
64
CrossRef citations to date
0
Altmetric
Research Article

Faecal Short-Chain Fatty Acids in Patients with Antibiotic-Associated Diarrhoea, before and after Faecal Enema Treatment

Pages 721-727 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Jacqueline C. Whittemore, Jennifer E. Stokes, Joshua M. Price & Jan S. Suchodolski. (2019) Effects of a synbiotic on the fecal microbiome and metabolomic profiles of healthy research cats administered clindamycin: a randomized, controlled trial. Gut Microbes 10:4, pages 521-539.
Read now
Chaitanya Pant, Abhishek Deshpande, Muhammad A. Altaf, Anil Minocha & Thomas J. Sferra. (2013) Clostridium difficile infection in children: a comprehensive review. Current Medical Research and Opinion 29:8, pages 967-984.
Read now
Aijaz Ahmed Sofi, Ann Lynn Silverman, Sadik Khuder, Kjetil Garborg, Julie M. A Westerink & Ali Nawras. (2013) Relationship of symptom duration and fecal bacteriotherapy in Clostridium difficile infection-pooled data analysis and a systematic review. Scandinavian Journal of Gastroenterology 48:3, pages 266-273.
Read now
Christina Jorup-Rönström, Anders Håkanson, Staffan Sandell, Ove Edvinsson, Tore Midtvedt, Anna-Karin Persson & Elisabeth Norin. (2012) Fecal transplant against relapsing Clostridium difficile-associated diarrhea in 32 patients. Scandinavian Journal of Gastroenterology 47:5, pages 548-552.
Read now
A. Gustafsson, A. Berstad, S. Lund-Tønnesen, T. Midtvedt, E. Norin. (1999) The Effect of Faecal Enema on Five Microflora-Associated Characteristics in Patients with Antibiotic-Associated Diarrhoea. Scandinavian Journal of Gastroenterology 34:6, pages 580-586.
Read now

Articles from other publishers (58)

Alison T. Jess, George Hany Eskander, My H. Vu & Sonia Michail. (2023) Short-Chain Fatty Acid Levels after Fecal Microbiota Transplantation in a Pediatric Cohort with Recurrent Clostridioides difficile Infection. Metabolites 13:10, pages 1039.
Crossref
Noemi Strahm, Henriette Didriksen, Håvard Fretheim, Øyvind Molberg, Øyvind Midtvedt, Inger Nina Farstad, Tore Midtvedt, Knut E A Lundin, Lars Aabakken, Przemysław Błyszczuk, Oliver Distler, Gabriela Kania & Anna-Maria Hoffmann-Vold. (2023) Effects of faecal microbiota transplantation on the small intestinal mucosa in systemic sclerosis. Rheumatology 62:8, pages 2918-2929.
Crossref
Florence Van Herreweghen, Kim De Paepe, Massimo Marzorati & Tom Van de Wiele. (2021) Mucin as a Functional Niche Is a More Important Driver of In Vitro Gut Microbiota Composition and Functionality than Akkermansia muciniphila Supplementation . Applied and Environmental Microbiology 87:4.
Crossref
Alexander Khoruts, Christopher Staley & Michael J. Sadowsky. (2020) Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology. Nature Reviews Gastroenterology & Hepatology 18:1, pages 67-80.
Crossref
E. I. Sas, V. B. Grinevich & V. A. Barnakova. (2020) Fecal transplantation: clinical realities and prospects in the treatment of metabolic syndrome. Experimental and Clinical Gastroenterology 183:11, pages 102-112.
Crossref
Monica Gulati, Sachin Kumar Singh, Leander Corrie, Indu Pal Kaur & Lipika Chandwani. (2020) Delivery routes for faecal microbiota transplants: Available, anticipated and aspired. Pharmacological Research 159, pages 104954.
Crossref
Håvard Fretheim, Brian K. Chung, Henriette Didriksen, Espen S. Bækkevold, Øyvind Midtvedt, Cathrine Brunborg, Kristian Holm, Jørgen Valeur, Anders Heiervang Tennøe, Torhild Garen, Tore Midtvedt, Marius Trøseid, Hasse Zarè, May Brit Lund, Johannes R. Hov, Knut E. A. Lundin, Øyvind Molberg & Anna-Maria Hoffmann-Vold. (2020) Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial. PLOS ONE 15:5, pages e0232739.
Crossref
Hala M. Fadda. (2020) The Route to Palatable Fecal Microbiota Transplantation. AAPS PharmSciTech 21:3.
Crossref
Yuliia Holota, Taisa Dovbynchuk, Izumi Kaji, Igor Vareniuk, Natalia Dzyubenko, Tetiana Chervinska, Liudmyla Zakordonets, Viktoria Stetska, Liudmyla Ostapchenko, Tetiana Serhiychuk & Ganna Tolstanova. (2019) The long-term consequences of antibiotic therapy: Role of colonic short-chain fatty acids (SCFA) system and intestinal barrier integrity. PLOS ONE 14:8, pages e0220642.
Crossref
Alexandra Nowak, Magnus Hedenstierna, Johan Ursing, Christer Lidman & Piotr Nowak. (2019) Efficacy of Routine Fecal Microbiota Transplantation for Treatment of Recurrent Clostridium difficile Infection: A Retrospective Cohort Study . International Journal of Microbiology 2019, pages 1-7.
Crossref
P. Benno, E. Norin, T. Midtvedt & P.M. Hellström. (2019) Therapeutic potential of an anaerobic cultured human intestinal microbiota, ACHIM, for treatment of IBS. Best Practice & Research Clinical Gastroenterology 40-41, pages 101607.
Crossref
Chara Litou, Angela Effinger, Edmund S Kostewicz, Karl J Box, Nikoletta Fotaki & Jennifer B Dressman. (2019) Effects of medicines used to treat gastrointestinal diseases on the pharmacokinetics of coadministered drugs: a PEARRL Review. Journal of Pharmacy and Pharmacology 71:4, pages 643-673.
Crossref
Szabolcs Vigvári, Áron Vincze, Jenő Solt, Dávid Sipos, Zsófia Feiszt, Beáta Kovács, Ágnes Kappéter & Zoltán Péterfi. (2018) Experiences with fecal microbiota transplantation in Clostridium difficile infections via upper gastrointestinal tract. Acta Microbiologica et Immunologica Hungarica 66:2, pages 179-188.
Crossref
Alice Y. GuhPreeta K. Kutty. (2018) Clostridioides difficile Infection . Annals of Internal Medicine 169:7, pages ITC49-ITC64.
Crossref
Jacqueline C. Whittemore, Jennifer E. Stokes, Nicole L. Laia, Joshua M. Price & Jan S. Suchodolski. (2018) Short and long-term effects of a synbiotic on clinical signs, the fecal microbiome, and metabolomic profiles in healthy research cats receiving clindamycin: a randomized, controlled trial. PeerJ 6, pages e5130.
Crossref
Roy J Hopkins & Robert B Wilson. (2018) Treatment of recurrent Clostridium difficile colitis: a narrative review. Gastroenterology Report 6:1, pages 21-28.
Crossref
Szabolcs Vigvári, Dávid Sipos, Jenő Solt, Áron Vincze, Béla Kocsis, Zsuzsanna Nemes, Ágnes Kappéter, Zsófia Feiszt, Beáta Kovács & Zoltán Péterfi. (2017) Faecal microbiota transplantation for Clostridium difficile infection using a lyophilized inoculum from non-related donors: A case series involving 19 patients. Acta Microbiologica et Immunologica Hungarica 66:1, pages 69-78.
Crossref
Massimo Marzorati, Ramiro Vilchez‐Vargas, Julie Vanden Bussche, Pilar Truchado, Ruy Jauregui, Racha Ahmad El Hage, Dietmar H. Pieper, Lynn Vanhaecke & Tom Van de Wiele. (2016) High‐fiber and high‐protein diets shape different gut microbial communities, which ecologically behave similarly under stress conditions, as shown in a gastrointestinal simulator. Molecular Nutrition & Food Research 61:1.
Crossref
Sinan Wang, Mengque Xu, Weiqiang Wang, Xiaocang Cao, Meiyu Piao, Samiullah Khan, Fang Yan, Hailong Cao & Bangmao Wang. (2016) Systematic Review: Adverse Events of Fecal Microbiota Transplantation. PLOS ONE 11:8, pages e0161174.
Crossref
Silan Gu, Yunbo Chen, Xuewu Zhang, Haifeng Lu, Tao Lv, Ping Shen, Longxian Lv, Beiwen Zheng, Xiawei Jiang & Lanjuan Li. (2016) Identification of key taxa that favor intestinal colonization of Clostridium difficile in an adult Chinese population. Microbes and Infection 18:1, pages 30-38.
Crossref
Hua Xu, Anthony McCoy, Jing Li, Yang Zhao & Fayez K. Ghishan. (2015) Sodium butyrate stimulates NHE8 expression via its role on activating NHE8 basal promoter activity. American Journal of Physiology-Gastrointestinal and Liver Physiology 309:6, pages G500-G505.
Crossref
Szabolcs Vigvári, Zsuzsanna Nemes, Áron Vincze, Jenő Solt, Dávid Sipos, Zsófia Feiszt, Ágnes Kappéter, Beáta Kovács & Zoltán Péterfi. (2014) Experience with fecal microbiota transplantation in the treatment of Clostridium difficile infection . Orvosi Hetilap 155:44, pages 1758-1762.
Crossref
Christoph Lübbert, Endres John & Lutz von Müller. (2014) Clostridium Difficile Infection. Deutsches Ärzteblatt international.
Crossref
S. Sha, J. Liang, M. Chen, B. Xu, C. Liang, N. Wei & K. Wu. (2014) Systematic review: faecal microbiota transplantation therapy for digestive and nondigestive disorders in adults and children. Alimentary Pharmacology & Therapeutics 39:10, pages 1003-1032.
Crossref
George H. Russell, Jess L. Kaplan, Ilan Youngster, Mariah Baril‐Dore, Lili Schindelar, Elizabeth Hohmann & Harland S. Winter. (2014) Fecal Transplant for Recurrent Clostridium difficile Infection in Children With and Without Inflammatory Bowel Disease . Journal of Pediatric Gastroenterology and Nutrition 58:5, pages 588-592.
Crossref
V.L. McCune, J.K. Struthers & P.M. Hawkey. (2014) Faecal transplantation for the treatment of Clostridium difficile infection: a review. International Journal of Antimicrobial Agents 43:3, pages 201-206.
Crossref
M. Kazanowski, S. Smolarek, F. Kinnarney & Z. Grzebieniak. (2013) Clostridium difficile: epidemiology, diagnostic and therapeutic possibilities—a systematic review. Techniques in Coloproctology 18:3, pages 223-232.
Crossref
Alexander Kleger, Jacqueline Schnell, Andreas Essig, Martin Wagner, Martin Bommer, Thomas Seufferlein & Georg Härter. (2013) Fecal Transplant in Refractory Clostridium difficile Colitis. Deutsches Ärzteblatt international.
Crossref
Faith Rohlke & Neil Stollman. (2012) Fecal microbiota transplantation in relapsing Clostridium difficile infection . Therapeutic Advances in Gastroenterology 5:6, pages 403-420.
Crossref
J. L. Anderson, R. J. Edney & K. Whelan. (2012) Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 36:6, pages 503-516.
Crossref
. (2012) Discussion from the 24th Marabou Symposium: Nutrition and the human microbiome. Nutrition Reviews 70, pages S57-S86.
Crossref
Sang Woo Kim. (2012) Treatment of Refractory or Recurrent Clostridium difficile Infection . The Korean Journal of Gastroenterology 60:2, pages 71.
Crossref
Chaitanya Pant, Thomas J. Sferra, Abhishek Deshpande & Anil Minocha. (2011) Clinical approach to severe Clostridium difficile infection: Update for the hospital practitioner. European Journal of Internal Medicine 22:6, pages 561-568.
Crossref
Ethan Gough, Henna Shaikh & Amee R. Manges. (2011) Systematic Review of Intestinal Microbiota Transplantation (Fecal Bacteriotherapy) for Recurrent Clostridium difficile Infection. Clinical Infectious Diseases 53:10, pages 994-1002.
Crossref
Lawrence J. Brandt & Sheela S. Reddy. (2011) Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection. Journal of Clinical Gastroenterology 45, pages S159-S167.
Crossref
J. Landy, H. O. Al-Hassi, S. D. McLaughlin, A. W. Walker, P. J. Ciclitira, R. J. Nicholls, S. K. Clark & A. L. Hart. (2011) Review article: faecal transplantation therapy for gastrointestinal disease. Alimentary Pharmacology & Therapeutics 34:4, pages 409-415.
Crossref
Allen C ChengJohn K FergusonMichael J RichardsJennifer M RobsonGwendolyn L GilbertAlistair McGregorSally RobertsTony M KormanThomas V Riley. (2011) Australasian Society for Infectious Diseases guidelines for the diagnosis and treatment of Clostridium difficile infection. Medical Journal of Australia 194:7, pages 353-358.
Crossref
Martin J. Grehan, Thomas Julius Borody, Sharyn M. Leis, Jordana Campbell, Hazel Mitchell & Antony Wettstein. (2010) Durable Alteration of the Colonic Microbiota by the Administration of Donor Fecal Flora. Journal of Clinical Gastroenterology 44:8, pages 551-561.
Crossref
Faith Rohlke, Christina M. Surawicz & Neil Stollman. (2010) Fecal Flora Reconstitution for Recurrent Clostridium difficile Infection: Results and Methodology. Journal of Clinical Gastroenterology 44:8, pages 567-570.
Crossref
Sonia S. Yoon & Lawrence J. Brandt. (2010) Treatment of Refractory/Recurrent C. difficile-associated Disease by Donated Stool Transplanted Via Colonoscopy. Journal of Clinical Gastroenterology 44:8, pages 562-566.
Crossref
Alexander Khoruts, Johan Dicksved, Janet K. Jansson & Michael J. Sadowsky. (2010) Changes in the Composition of the Human Fecal Microbiome After Bacteriotherapy for Recurrent Clostridium difficile-associated Diarrhea. Journal of Clinical Gastroenterology 44:5, pages 354-360.
Crossref
Stuart H. Cohen, Dale N. Gerding, Stuart Johnson, Ciaran P. Kelly, Vivian G. Loo, L. Clifford McDonald, Jacques Pepin & Mark H. Wilcox. (2015) Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infection Control & Hospital Epidemiology 31:05, pages 431-455.
Crossref
Johan S. Bakken. (2009) Fecal bacteriotherapy for recurrent Clostridium difficile infection. Anaerobe 15:6, pages 285-289.
Crossref
Perry Hookman & Jamie S Barkin. (2009) Clostridium diffcile associated infection, diarrhea andcolitis. World Journal of Gastroenterology 15:13, pages 1554.
Crossref
L. Beaugerie & F. Barbut. 2009. Post’U FMC-HGE. Post’U FMC-HGE 153 162 .
Rebecca S. McConnico, Timothy W. Morgan, Cathleen C. Williams, Jeremy D. Hubert & Rustin M. Moore. (2008) Pathophysiologic effects of phenylbutazone on the right dorsal colon in horses. American Journal of Veterinary Research 69:11, pages 1496-1505.
Crossref
Jennifer Halsey. (2008) Current and future treatment modalities for Clostridium difficile -associated disease . American Journal of Health-System Pharmacy 65:8, pages 705-715.
Crossref
Catherina JM Koning, Daisy MAE Jonkers, Ellen E Stobberingh, Linda Mulder, Frans M Rombouts & Reinhold W Stockbrügger. (2008) The Effect of a Multispecies Probiotic on the Intestinal Microbiota and Bowel Movements in Healthy Volunteers Taking the Antibiotic Amoxycillin. The American Journal of Gastroenterology 103:1, pages 178-189.
Crossref
Christos Gougoulias, Kieran M. Tuohy & Glenn R. Gibson. (2007) Dietary-based gut flora modulation against Clostridium difficile onset . Food Science & Technology Bulletin: Functional Foods 4:4, pages 31-41.
Crossref
Laurent Beaugerie. (2004) Étiologie et pathogenèse des diarrhées post-antibiotiques. Revue Française des Laboratoires 2004:368, pages 21-25.
Crossref
Thomas J Borody, Eloise F Warren, Sharyn M Leis, Rosa Surace, Ori Ashman & Steven Siarakas. (2004) Bacteriotherapy Using Fecal Flora. Journal of Clinical Gastroenterology 38:6, pages 475-483.
Crossref
Laurent Beaugerie & Jean-Claude Petit. (2004) Antibiotic-associated diarrhoea. Best Practice & Research Clinical Gastroenterology 18:2, pages 337-352.
Crossref
Thomas J. Borody, Eloise F. Warren, Sharyn Leis, Rosa Surace & Ori Ashman. (2003) Treatment of Ulcerative Colitis Using Fecal Bacteriotherapy. Journal of Clinical Gastroenterology 37:1, pages 42-47.
Crossref
Takamitsu Tsukahara & Kazunari Ushida. (2002) Succinate accumulation in pig large intestine during antibiotic-associated diarrhea and the constitution of succinate-producing flora.. The Journal of General and Applied Microbiology 48:3, pages 143-154.
Crossref
Pawel R. Kiela, Eric R. Hines, James F. Collins & Fayez K. Ghishan. (2001) Regulation of the rat NHE3 gene promoter by sodium butyrate. American Journal of Physiology-Gastrointestinal and Liver Physiology 281:4, pages G947-G956.
Crossref
Seth E. Persky & Lawrence J. Brandt. (2000) Treatment of recurrent Clostridium difficile-associated diarrhea by administration of donated stool directly through a colonoscope. The American Journal of Gastroenterology 95:11, pages 3283-3285.
Crossref
Thomas J. Borody. (2000) "flora power"-fecal bacteria cure chronic C. difficile diarrhea. The American Journal of Gastroenterology 95:11, pages 3028-3029.
Crossref
Ariel Malamud & Keith T. Wilson. (2000) Treatment of gastrointestinal infections. Current Opinion in Gastroenterology 16:1, pages 51-55.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.